Paul Dykes, MD
Nephrology · Brookhaven, MSNPI 1861474827
Payments from drug & device makers
Across 390 payments — averaging $883.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Akebia Therapeutics Inc$200K
- OPKO Pharmaceuticals, LLC$114K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$25K
- AbbVie$2K
- AstraZeneca$1K
- Bayer$452
- plus $2K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Akebia Therapeutics Inc | 195 | $199,830 |
| OPKO Pharmaceuticals, LLC | 24 | $113,525 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $25,453 |
| AbbVie | 1 | $2,117 |
| AstraZeneca | 43 | $1,007 |
| Bayer | 25 | $452 |
| Aurinia Pharma U.S., Inc. | 14 | $304 |
| Fresenius USA Marketing, Inc. | 12 | $253 |
| Vifor Pharma, Inc. | 12 | $192 |
| Calliditas Therapeutics US Inc. | 9 | $173 |
| Novartis | 6 | $172 |
| ANI Pharmaceuticals, Inc. | 8 | $152 |
| Amgen | 7 | $147 |
| Mallinckrodt Hospital Products Inc. | 5 | $87 |
| Ardelyx, Inc. | 3 | $79 |
| Sunovion Pharmaceuticals Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Travere Therapeutics, Inc. | 2 | $50 |
| Boehringer Ingelheim | 3 | $45 |
| GSK | 2 | $40 |
| Mallinckrodt Enterprises LLC | 2 | $37 |
| Merck | 2 | $32 |
| Johnson & Johnson | 2 | $31 |
| Scpharmaceuticals Inc. | 1 | $25 |
| Shield Therapeutics Inc | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
How this compares
$344,399 in reported general payments places this provider in the 95th percentile of 105 nephrology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Brookhaven
- Richard MillerBrookhaven$772K
- Thomas WooldridgeTupelo$1.6M
- Angela RileyOxford$706K
- Mohit AhujaFlowood$427K
- Douglas LanierGulfport$422K
- Marcus BrittonTupelo$339K
- Thomas DunnColumbus$295K
- Kent KirchnerJackson$88K
- Erica HopkinsGulfport$70K
- Anita BasuJackson$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.